Replies to post #501780 on Anavex Life Sciences Corp (AVXL)

[ohsaycanyousee82]

Didn’t Kun Jin come on board around the time that decision would have been made?

Would he not have recommended that a confirmatory trial been done if he felt one was needed from his FDA experience/expertise?

They did not initiate and he has not left for another gig.

[ExtremelyBullishZig]

The continued post hoc analysis is to keep up demand so they can continue to dilute.

[boi568]

I am discussing the 2b/3 without the follow ups. What is your issue there that triggers your second trial requirement -- truthfulness of the underlying numbers or distrust of stat sig p values?

[catdaddy]

As you stated, "My chance of CMA is 75% - possibly too generous"

So, which is it? 75% or significantly less? Need you on record.